Sort   by:  
 Page size 
UnknownRadiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
Not available
S-EPMC9969528 | biostudies-literature
UnknownOpen-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer.
Not available
S-EPMC8280094 | biostudies-literature
UnknownA multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.
Not available
S-EPMC4010705 | biostudies-literature
UnknownEfficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
Not available
S-EPMC3107731 | biostudies-literature
UnknownThe 15-Year Survival Advantage: Immune Resilience as a Salutogenic Force in Healthy Aging.
Not available
S-EPMC12266754 | biostudies-literature
UnknownImmune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection.
Not available
S-EPMC10264401 | biostudies-literature
Sort   by:  
 Page size